Mata, first Goldseeker is absolutely correct in questioning the naked shorting. I have no reason to believe this either UNLESS I SEE A PRESS RELEASE or definitive proof the SEC has been contacted. 3.500.000 shares FORCED TO COVER would bring a massive surge in the share price since the volume is so anemic in this stock.
Second, as far as the last "advertisement" of BOCX, I thought to myself that the only way the neutral rating made any sense whatsoever would be if there was concrete substantial news on the horizon where this "advertisement" becomes an endorsement, and they change their recommendation to a buy. A risky tactic and means nothing unless it is something where we will see any revenue in the near future. If that is not the case, then management's PR skills really need to be called into question to squander capital that was raised that caused a great amount of dilution to loyal shareholders. Alot of great progress in the recaf technology has kept us invested, and we (shareholders) need to see at least some of the promises fulfilled. The best step forward would be moving toward the FDA approval.
